Skip to content

Patient Case: Basic Calcium Phosphate (BCP) Deposition Disease

Patient case fields
Patient Background

A 55-year-old female presents to the orthopedic clinic with progressive shoulder pain and stiffness over the past six months. She describes the pain as deep, aching, and worse with movement, particularly when lifting her arm above her head. She denies any history of trauma but reports mild swelling and warmth around the shoulder. Over-the-counter pain medications have provided only minimal relief.

Discussion

Medical History & Social Background

• Medical history: Hypertension, osteoarthritis in the knees, and type 2 diabetes mellitus.

• No prior history of gout, rheumatoid arthritis, or systemic connective tissue diseases.

• Occupation: Office worker with limited physical activity.

• Social history: No alcohol use, non-smoker.

Physical Examination

• Localized tenderness and swelling around the right shoulder.

• Restricted range of motion, especially with abduction and external rotation.

• No significant joint erythema, but mild warmth is noted.

• Negative provocative tests for rotator cuff tears.

• No signs of systemic inflammation (no fever, normal vital signs).

Laboratory & Imaging Findings

• Serum inflammatory markers (CRP, ESR): Normal.

• Serum calcium and phosphate levels: Normal.

• Serum uric acid: Normal.

• Synovial fluid analysis: No urate or pyrophosphate crystals, no infection.

• Shoulder X-ray: Periarticular calcifications in the rotator cuff tendons.

• Ultrasound: Confirms calcific deposits within the supraspinatus tendon, consistent with basic calcium phosphate (BCP) crystal deposition disease.

Diagnosis

The patient is diagnosed with basic calcium phosphate (BCP) deposition disease, specifically calcific tendinitis of the shoulder, which occurs due to hydroxyapatite crystal accumulation in periarticular structures.

Management Plan

1. Pain & Inflammation Control

• NSAIDs (e.g., ibuprofen, naproxen) for pain relief.

• Physical therapy to improve range of motion and prevent stiffness.

• Ultrasound-guided corticosteroid injection if symptoms persist.

2. Advanced Interventions for Refractory Cases

• Needle aspiration and lavage (barbotage) for persistent cases.

• Shockwave therapy to break down calcium deposits.

• Surgical removal in cases with severe functional impairment.

3. Monitoring & Prevention

• Regular follow-up with imaging to assess resolution or progression.

• Screening for metabolic disorders (though most cases occur in idiopathic settings).

• Lifestyle modifications, including shoulder-strengthening exercises.

Challenges & Considerations

Diagnosis is often delayed due to overlap with other shoulder pathologies (e.g., rotator cuff tears, osteoarthritis).

BCP crystals do not show up under polarized light microscopy, making them harder to identify than urate or pyrophosphate crystals.

Calcific deposits may resolve spontaneously but can cause prolonged symptoms in some patients.

Prognosis

Most cases resolve with conservative management, but some patients may experience chronic shoulder dysfunction, requiring more aggressive treatment. Early intervention with physical therapy and anti-inflammatory medications is crucial for optimal outcomes.

Questions
1. What is the most likely diagnosis for this patient, given her symptoms and imaging findings?

A) Gout

B) Rheumatoid arthritis

C) Basic calcium phosphate (BCP) deposition disease

D) Calcium pyrophosphate deposition disease (CPPD)

2. Which of the following is the most characteristic imaging finding in BCP deposition disease?

A) Punched-out erosions with overhanging edges

B) Chondrocalcinosis in joint cartilage

C) Periarticular calcifications in tendons

D) Joint space narrowing with osteophyte formation

3. Why is synovial fluid analysis often unhelpful in diagnosing BCP deposition disease?

A) BCP crystals are too small to be seen under conventional light microscopy

B) Synovial fluid is always normal in BCP deposition disease

C) BCP crystals appear as rhomboid-shaped, positively birefringent structures

D) Synovial fluid analysis is unnecessary for diagnosing BCP deposition disease

4. What is the best initial treatment for this patient’s condition?

A) Methotrexate and hydroxychloroquine

B) Nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy

C) Allopurinol and colchicine

D) Long-term corticosteroids and immunosuppressants

Reveal answers

Answers

1. (C) Basic calcium phosphate (BCP) deposition disease

The patient’s gradual-onset shoulder pain, periarticular calcifications, and normal inflammatory markers are characteristic of BCP deposition disease. Gout and CPPD involve different crystal types and joint locations, while rheumatoid arthritis (RA) is an inflammatory polyarthritis that typically affects smaller joints.

2. (C) Periarticular calcifications in tendons

X-rays in BCP deposition disease often show calcific deposits in tendons, most commonly in the rotator cuff. This differs from chondrocalcinosis (CPPD) and joint erosions (gout).

3. (A) BCP crystals are too small to be seen under conventional light microscopy

Unlike urate or pyrophosphate crystals, BCP crystals (hydroxyapatite) are non-birefringent and too small to be seen under regular microscopy, making synovial fluid analysis less useful for diagnosis.

4. (B) Nonsteroidal anti-inflammatory drugs (NSAIDs) and physical therapy

NSAIDs help manage pain and inflammation, while physical therapy improves mobility and function. Methotrexate and hydroxychloroquine are used for autoimmune diseases, allopurinol is for gout, and long-term corticosteroids are not recommended due to side effects.

Are you a Medical Doctor?